MASTERCLASS: What CREST-2 Means for Carotid Disease Management episode artwork

EPISODE · Jun 10, 2026 · 26 MIN

MASTERCLASS: What CREST-2 Means for Carotid Disease Management

from Neurocritical Care Society Podcast

In this episode of the Neurocritical Care Society Podcast Masterclass series, hosts Stephan Mayer, MD, FCCM, FNCS, and Jon Rosenberg, MD, are joined by Seemant Chaturvedi, MD, professor of neurology and director of the Stroke Division at the University of Maryland, for an in-depth discussion on carotid disease, stroke prevention and the role of revascularization in clinical practice. The episode explores the historical impact of NASCET, key findings from the CREST-2 trial and the role of intensive medical management for patients with asymptomatic carotid stenosis. Dr. Chaturvedi also shares practical guidance for neurointensivists caring for patients with symptomatic carotid disease, including intervention timing, risk stratification and emerging diagnostic tools such as MRI plaque imaging and TCD microemboli monitoring. The views expressed on the NCS Podcast are solely those of the hosts and guests and do not necessarily reflect the opinions or official positions of the Neurocritical Care Society.

Episode metadata supplied by the publisher feed · Published Jun 10, 2026

Embed this episode

NOW PLAYING

MASTERCLASS: What CREST-2 Means for Carotid Disease Management

0:00 26:08

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Neurocritical Care Society Podcast?

This episode is 26 minutes long.

When was this Neurocritical Care Society Podcast episode published?

This episode was published on June 10, 2026.

Can I download this Neurocritical Care Society Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!